Clinical trial / 2015
High-dose lycopene, selenium, and green tea catechins showed adverse trends in prostate lesions.
Sixty men with premalignant prostate lesions received daily lycopene (35 mg), selenium (55 µg), and green tea catechins (600 mg), or placebo for 6 months. At re-biopsy in 53 men, prostate cancer was diagnosed in 10 men in the supplement group versus 3 in the placebo group (p = 0.053). Supplementation was also associated with altered microRNA expression linked to cancer progression, while PSA levels and symptom scores showed no significant differences.
- Study type
- Randomized controlled trial
- Who was studied
- 60 men with multifocal high-grade PIN or atypical small acinar proliferation
- What was measured
- Prostate cancer incidence on re-biopsy and prostate tissue microRNA expression
THE PAPER
A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
Gontero P, Marra G, Soria F, Oderda M, Zitella A, Baratta F, Chiorino G, Gregnanin I, Daniele L, Cattel L, Frea B, Brusa P. Prostate, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.